Cargando…
Rodent Models of Alcoholic Liver Disease: Role of Binge Ethanol Administration
Both chronic and acute (binge) alcohol drinking are important health and economic concerns worldwide and prominent risk factors for the development of alcoholic liver disease (ALD). There are no FDA-approved medications to prevent or to treat any stage of ALD. Therefore, discovery of novel therapeut...
Autores principales: | Ghosh Dastidar, Shubha, Warner, Jeffrey B., Warner, Dennis R., McClain, Craig J., Kirpich, Irina A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871972/ https://www.ncbi.nlm.nih.gov/pubmed/29342874 http://dx.doi.org/10.3390/biom8010003 |
Ejemplares similares
-
Ethanol and unsaturated dietary fat induce unique patterns of hepatic ω-6 and ω-3 PUFA oxylipins in a mouse model of alcoholic liver disease
por: Warner, Dennis R., et al.
Publicado: (2018) -
Liver-specific drug delivery platforms: Applications for the treatment of alcohol-associated liver disease
por: Warner, Jeffrey Barr, et al.
Publicado: (2022) -
Fat-1 Transgenic Mice With Augmented n3-Polyunsaturated Fatty Acids Are Protected From Liver Injury Caused by Acute-On-Chronic Ethanol Administration
por: Warner, Jeffrey, et al.
Publicado: (2021) -
Soluble Epoxide Hydrolase Inhibition in Liver Diseases: A Review of Current Research and Knowledge Gaps
por: Warner, Jeffrey, et al.
Publicado: (2020) -
Fpr2(−/−) Mice Developed Exacerbated Alcohol-Associated Liver Disease
por: Hardesty, Josiah E., et al.
Publicado: (2023)